tradmap

RANI Earnings Rani Therapeutics Holdings, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$1 -$1 $0 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $1M $3M 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$34M -$17M $0 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$1 -$0 $1 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $854000 $2M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$10M -$5M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–20 of 20
Q2 20262026-06-30-0.082026-08-1310-Q
Q1 20262026-03-31-0.042026-05-1510-Q
FY 20252025-12-31-0.452026-03-2610-K
Q3 20252025-09-30-0.502025-11-0610-Q
Q2 20262025-06-30-0.402026-08-1310-Q
Q1 20262025-03-31-0.222026-05-1510-Q
FY 20252024-12-31-1.052026-03-2610-K
Q3 20252024-09-30-0.782025-11-0610-Q
Q2 20252024-06-30-0.552025-08-0710-Q
Q1 20252024-03-31-0.292025-05-1310-Q
FY 20242023-12-31-1.332025-03-3110-K
Q3 20242023-09-30-1.062024-11-1410-Q
Q2 20242023-06-30-0.702024-08-0610-Q
Q1 20242023-03-31-0.332024-05-0610-Q
FY 20232022-12-31-1.282024-03-2010-K
Q3 20232022-09-300.932023-11-0810-Q
Q2 20232022-06-300.602023-08-1110-Q
Q1 20232022-03-310.292023-05-1010-Q
FY 20222021-12-31-0.432023-03-2210-K
Q3 20222021-09-30-0.162022-11-1010-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.